Dexcom (DXCM) Shares Issued (2010 - 2026)

Dexcom (DXCM) has 17 years of Shares Issued data on file, last reported at $12.7 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $12.7 million, down 10.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.6 million (down 8.28% YoY), and the FY2025 annual result was $28.1 million, changed 0.35% from the prior year.
• Shares Issued eased to $12.7 million in Q1 2026 per DXCM's latest filing, from $13.9 million in the prior quarter.
• Over five years, Shares Issued peaked at $14.8 million in Q3 2024 and troughed at $10.1 million in Q1 2022.
• A 5-year average of $13.1 million and a median of $13.4 million in 2024 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2023 and 2026: Shares Issued grew 21.78% in 2023, then decreased 10.56% in 2026.
• A 5-year view of Shares Issued shows it stood at $12.4 million in 2022, then increased by 15.32% to $14.3 million in 2023, then increased by 3.5% to $14.8 million in 2024, then declined by 6.08% to $13.9 million in 2025, then dropped by 8.63% to $12.7 million in 2026.
• Business Quant data shows DXCM's Shares Issued at $12.7 million in Q1 2026, $13.9 million in Q3 2025, and $14.2 million in Q1 2025.